Date Received: 07-02-2025 / Date Published: 21-02-2025
Nanosilver plasma, a new material created through the electrochemical silver plasma method, is believed for its higher potent antimicrobial activity against different types of bacteria. However, its application in aquaculture has yet to be extensively researched. This study evaluated the efficacy of nanosilver plasma in eliminating pathogenic bacteria Streptococcus agalactiae in tilapia, aiming to lay the groundwork for its practical use in disease prevention and treatment in aquaculture. Nanosilver plasma was examined for its capacity to inhibit bacterial growth under in vitro conditions, its safety on fish and its disinfection capability in experimental treatments. The research results demonstrate that nanosilver plasma at concentrations of 0.25, 0.5, and 1 ppm inhibited 97.8%, 99.9%, and 100% of S. agalactiae, respectively, under in vitro conditions and was entirely safe for tilapia when used for soaking and sterilization. Nanosilver plasma at 0.5ppm exhibits antiseptic capabilities comparable to BKC (0.5ppm) and Glutandehyl (0.05ppm) in treating diseases caused by S. agalactiae in tilapia, alongside the antibiotic amoxicillin(40 mg/kg fish) under experimental conditions.